TABLE 3.
Circulatory and Fecal Markers Before and After Treatment of Patients With IBD
| Active Inflammation | After Treatment | P * | |
|---|---|---|---|
| PGA (mean ± SD) | 2 ± 1 | 1 ± 1 | 0.001 |
| CRP, mg/L (mean ± SD) | 14.1 ± 20.6 | 1.3 ± 0.5 | 0.047 |
| Plasma albumin, g/L (mean ± SD) | 34.5 ± 4.6 | 37.4 ± 1.7 | 0.219 |
| Blood leukocytes × 109/L (mean ± SD) | 8.5 ± 4.3 | 6.6 ± 3.2 | 0.147 |
| Fecal calprotectin, mg/kg (mean ± SD) | 1033 ± 959 | 1051 ± 1976 | 0.063 |
*Wilcoxon signed-ranks test, active inflammation vs after treatment (paired samples only).
n = 15.